Caricamento...
Novel strategies for immuno-oncology breakthroughs with cell therapy
Cell therapy has evolved rapidly in the past several years with more than 250 clinical trials ongoing around the world. While more indications of cellular therapy with chimeric antigen receptor – engineered T cells (CAR-T) are approved for hematologic malignancies, new concepts and strategies of cel...
Salvato in:
| Pubblicato in: | Biomark Res |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8325826/ https://ncbi.nlm.nih.gov/pubmed/34332618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00316-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|